TY  - JOUR
AU  - Trigos, Anna Sofia
AU  - Pasam, Anupama
AU  - Banks, Patricia
AU  - Wallace, Roslyn
AU  - Guo, Christina
AU  - Keam, Simon
AU  - Thorne, Heather
AU  - kConFab
AU  - Mitchell, Catherine
AU  - Lade, Stephen
AU  - Clouston, David
AU  - Hakansson, Alexander
AU  - Liu, Yang
AU  - Blyth, Benjamin
AU  - Murphy, Declan
AU  - Lawrentschuk, Nathan
AU  - Bolton, Damien
AU  - Moon, Daniel
AU  - Darcy, Phil
AU  - Haupt, Ygal
AU  - Williams, Scott G
AU  - Castro, Elena
AU  - Olmos, David
AU  - Goode, David
AU  - Neeson, Paul
AU  - Sandhu, Shahneen
PY  - 2022
DO  - 10.1136/jitc-2021-003744
UR  - http://hdl.handle.net/10668/20159
T2  - Journal for immunotherapy of cancer
AB  - Aberrations in homologous recombination repair (HRR) genes are emerging as important biomarkers for personalized treatment in prostate cancer (PCa). HRR deficiency (HRD) could affect the tumor immune microenvironment (TIME), potentially contributing...
LA  - en
KW  - gene expression profiling
KW  - genetic markers
KW  - prostatic neoplasms
KW  - tumor microenvironment
KW  - Germ-Line Mutation
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - Male
KW  - Prostatic Neoplasms
KW  - Recombinational DNA Repair
KW  - Tumor Microenvironment
TI  - Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.
TY  - research article
VL  - 10
ER  -